SCHEMBL6635781

SCHEMBL6635781

CCOC(=O)Cn1c(COc2ccc(C#N)cc2)nc2cc(NS(=O)(=O)CCCN(C)C)ccc21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
NPC1 O15118 1/20 0.42
NLRP3 Q96P20 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CACNA1H O95180 1/20 0.39
CACNA1B Q00975 1/20 0.39
CNR2 P34972 4/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CNR1 P21554 2/20 0.37
SCN9A Q15858 1/20 0.36
ALOX5AP P20292 2/20 0.35
P2RX3 P56373 1/20 0.35
BRPF1 P55201 1/20 0.35
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6633282 0.94 CACNA1H (0.39) MAPTNPC1NLRP3NPSR1HTT
SCHEMBL6636378 0.88 F10 (0.43) MAPTNPC1NLRP3NPSR1CNR2
SCHEMBL6639192 0.84 MAPT (0.40) MAPTNPC1NLRP3NPSR1HTT
SCHEMBL6635871 0.83 BRPF1 (0.48) MAPTNPC1NLRP3NPSR1HTT
SCHEMBL8028358 0.83 CNR2 (0.46) CNR2CNR1
SCHEMBL6640165 0.82 F10 (0.39) MAPTNPC1NLRP3NPSR1CNR2
SCHEMBL6635786 0.81 MAPT (0.44) MAPTNPC1NLRP3NPSR1HTT
SCHEMBL8028048 0.79 CNR2 (0.44) CNR2CNR1
SCHEMBL6642117 0.79 F2 (0.47) MAPTNPC1NLRP3NPSR1HTT
SCHEMBL6634381 0.79 F10 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed